Hematologic NeoplasmsBone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousLeukemiaWhole-Body IrradiationHematopoietic Stem Cell TransplantationTransplantation ConditioningBone and BonesAnemia, AplasticTransplantation ChimeraTissue DonorsLiver TransplantationGraft SurvivalBusulfanHistocompatibility TestingHistocompatibilityBone Marrow PurgingHematopoietic Stem CellsCyclophosphamideLeukemia, Myeloid, AcuteRecurrenceTransplantation, IsogeneicTreatment OutcomeBone Marrow DiseasesHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCombined Modality TherapyPrecursor Cell Lymphoblastic Leukemia-LymphomaKidney TransplantationLymphoma, Non-HodgkinLeukemia, MyeloidImmunosuppressive AgentsMyelodysplastic SyndromesMice, Inbred C57BLRemission InductionTime FactorsRadiation ChimeraLymphomaBone Marrow ExaminationGraft RejectionRetrospective StudiesHepatic Veno-Occlusive DiseaseAcute DiseaseStem Cell TransplantationTransplantation ImmunologyLymphocyte DepletionSurvival AnalysisLeukocyte TransfusionBone RemodelingImmunosuppressionBone Marrow NeoplasmsMultiple MyelomaHematologic DiseasesHLA AntigensGraft vs Host ReactionT-LymphocytesLymphocyte TransfusionChimeraHeart TransplantationSurvival RateAntineoplastic Combined Chemotherapy ProtocolsGraft vs Tumor EffectActuarial AnalysisSevere Combined ImmunodeficiencyCord Blood Stem Cell TransplantationCyclosporineColony-Forming Units AssayFollow-Up StudiesLung TransplantationGraft vs Leukemia EffectNuclear FamilyBone DensityOpportunistic InfectionsHodgkin DiseaseLeukocyte CountDisease-Free SurvivalImmunocompromised HostCell DifferentiationPrognosisGranulocyte Colony-Stimulating FactorCytarabineFlow CytometryCarmustineOrgan TransplantationMelphalanCytomegalovirus InfectionsPancytopeniaPeripheral Blood Stem Cell TransplantationNeoplasmsEtoposideMice, Inbred BALB CFatal OutcomeNeutropeniaAntilymphocyte SerumBone ResorptionSpleen